Agios Pharmaceuticals Inc

24 sie 2026, 19:36 UTC

Agios Pharmaceuticals Inc shares are lower today, continuing a decline since Friday's close amid broader market volatility linked to geopolitical events.

21 sie 2026, 19:36 UTC

Agios Pharmaceuticals Inc shares are lower during Friday's session amid rising U.S. Treasury yields and ongoing geopolitical tensions. No specific news was identified.

20 sie 2026, 20:01 UTC

Agios Pharmaceuticals Inc. shares are lower today, driven by a significant downturn in the Biotechnology sector and heightened trading volume.

19 sie 2026, 20:06 UTC

Agios Pharmaceuticals shares are higher today, though they pulled back from a session high. Broader market sentiment may be influenced by rising cryptocurrency values.

18 sie 2026, 22:51 UTC

Agios Pharmaceuticals shares are lower in after-market hours, amid broader negative sentiment linked to rising sovereign bond yields and persistent inflation risks.

17 sie 2026, 19:41 UTC

Agios Pharmaceuticals shares are rising as Cantor Fitzgerald maintains an Overweight rating ahead of the November 1 PDUFA date for mitapivat.

14 sie 2026, 19:46 UTC

Agios Pharmaceuticals Inc shares are higher today, though no specific news explains the movement. Earlier, shares peaked before dipping later in the session.

12 sie 2026, 20:01 UTC

Agios Pharmaceuticals Inc shares are higher today amid unusually high trading volume. The stock has gained significantly since Tuesday's close.

11 sie 2026, 19:26 UTC

Agios Pharmaceuticals Inc shares are higher today, with no specific news driving the move. Market focus remains on upcoming U.S. inflation reports.

10 sie 2026, 21:01 UTC

Agios Pharmaceuticals Inc shares are lower in after-market trading, with no specific news identified to explain the decline. The stock remains below its 20-day moving average.

6 sie 2026, 19:32 UTC

Agios Pharmaceuticals shares are higher today, continuing an upward trend since Wednesday. The stock peaked earlier in the session before a slight pullback.

5 sie 2026, 19:56 UTC

Agios Pharmaceuticals is under investigation regarding its decision on tebapivat, contributing to lower trading activity today amid ongoing investor concerns.

4 sie 2026, 20:02 UTC

Agios Pharmaceuticals Inc shares are higher today amid broader market gains, supported by falling crude oil prices and comments on potential peace talks with Iran.

3 sie 2026, 20:06 UTC

Agios Pharmaceuticals Inc shares are higher today, continuing an upward trend since Friday's close. No specific news was identified to explain the movement.

31 lip 2026, 22:51 UTC

Agios Pharmaceuticals Inc. shares are lower in after-market hours, reflecting broader market declines amid mixed tech earnings and rising U.S. Treasury yields.

30 lip 2026, 20:08 UTC

Agios Pharmaceuticals shares are lower today amid mixed economic signals and unusually high trading volume. The stock has declined since Wednesday's close.

29 lip 2026, 20:51 UTC

Agios Pharmaceuticals Inc shares gained in after-market trading, rebounding from a session low despite broader market pressures from rising crude oil prices and geopolitical tensions.

28 lip 2026, 20:02 UTC

Agios Pharmaceuticals shares are lower amid an investigation into potential claims following the halted development of tebapivat for sickle cell disease.

27 lip 2026, 20:01 UTC

Agios Pharmaceuticals Inc shares are higher during Monday's session, reaching a notable peak earlier in the day. No specific news was identified for the move.

24 lip 2026, 23:21 UTC

Agios Pharmaceuticals shares are higher in after-market trading, supported by a decline in initial jobless claims, indicating a robust labor market.

22 lip 2026, 22:41 UTC

Agios Pharmaceuticals shares are lower in after-market trading, continuing a three-session decline amid broader market concerns over rising crude oil prices and inflation.

21 lip 2026, 19:01 UTC

Agios Pharmaceuticals shares declined after discontinuing tebapivat development for sickle cell disease, despite some trial improvements. The stock remains lower since Monday's close.